The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The global transfection reagents and equipment market is on a trajectory of robust growth, with a forecasted increase from $1.31 billion in 2022 to $1.46 billion in 2023 at a compound annual growth rate (CAGR) of 11.6%. Looking further ahead, the market is expected to reach $2.20 billion in 2027 at a CAGR of 10.8%. This upward trend is underpinned by several key factors, the most significant being the rising number of cancer patients worldwide.

The Role of Transfection in Cancer Research
Cancer is a disease characterized by abnormal and uncontrolled cell growth. In the fight against this formidable adversary, transfection reagents play a crucial role. Researchers utilize these reagents to introduce foreign genetic material, such as plasmid DNA or RNA molecules, into cells. This enables investigations into various aspects of cancer biology, including gene expression studies, gene silencing, drug screening, and target validation.

To put this into perspective, in 2021, the American Cancer Society reported 1.8 million new cancer cases diagnosed in 2020. Moreover, data from the National Cancer Institute in September 2020 showed 1,806,590 new cancer cases in the United States, accounting for 43% of all cancer diagnoses in men that year. These statistics underscore the growing need for advanced tools and technologies to combat cancer. Consequently, the rising number of cancer patients worldwide is a significant driver for the growth of the transfection reagents and equipment market.

Key Players in the Market
In this dynamic market, several major players are making significant contributions. Names like Thermo Fisher Scientific Inc., Promega Corporation, Qiagen N.V., and Bio-Rad Laboratories Inc. are among the leaders in this sector. Additionally, Maxcyte Inc., Lonza Group Ltd., Merck KGaA, and OriGene Technologies Inc., along with others like PromoCell GmbH, PerkinElmer Inc., Agilent Technologies Inc., and more, are shaping the industry landscape.

Innovations Fueling Market Growth
One of the notable trends driving the transfection reagents and equipment market is the emphasis on product innovation. Major companies in this sector are keen on developing groundbreaking products to maintain their market positions. A recent example of this trend is the introduction of the in vivo-jetRNA+ transfection reagent by Polyplus-Transfection SA in September 2022.

This innovative product is designed for in vivo mRNA delivery using a preformed liposome formulation. Notably efficient and scalable, it can deliver mRNA to various tissues and cell types safely and with high tolerability. This makes it a promising candidate for developing new gene therapies. The ready-to-use nature of this reagent eliminates the need for formulation stages, and its stable liposome size facilitates mRNA delivery at varying concentrations over time. Applications of this technology include prophylactic vaccinations, mRNA treatments for conditions like cancer therapy and rare diseases, and gene editing.

Market Segmentation
The global transfection reagents and equipment market is divided into various segments:

1. Products: The market is categorized by products into instruments and reagent and kits.
2. Types of Molecule: Transfection reagents are classified based on the type of molecule they are designed to deliver. This includes plasmid DNA, DNA oligonucleotides, small interfering RNA (siRNA), proteins, ribonucleoprotein complexes (RNPs), and other molecules.
3. Organism: The market also considers the organism for which the transfection reagents are designed. This includes bacteria, mammalian cells, fungi, plants, and viruses.
4. End User: The end users of these reagents span a broad spectrum, including biopharma, contract research organizations (CROs), contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs), academia, hospitals, clinical labs, and other end users.

Regional Insights
In 2022, North America was the largest region in the transfection reagents and equipment market, reflecting the region’s advanced healthcare infrastructure and strong research and development capabilities. However, it is the Asia-Pacific region that is poised to be the fastest-growing region in the forecast period, indicating the global reach and applicability of transfection technologies.

View More On The Transfection Reagents And Equipment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/transfection-reagents-and-equipment-global-market-report

Request A Sample Of The Global Transfection Reagents And Equipment Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=10780&type=smp

The Transfection Reagents And Equipment Global Market Report 2023  provides a comprehensive overview on the transfection reagents and equipment market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Cell Culture Consumables And Equipment Global Market Report 2023
Hematology Diagnostic Devices And Equipment Global Market Report 2023
PCR And Realtime PCR Testing Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model